HDAC9 and congestive heart failure: Remarkably, HDAC inhibitors (HDACis) were found to inhibit myofibroblast activation, reverse interstitial cardiac fibrosis in congestive heart failure, and induce cell apoptosis, demonstrating their potential therapeutic value.